Follow
Itamar Megiddo
Title
Cited by
Cited by
Year
Health and economic benefits of public financing of epilepsy treatment in India: An agent‐based simulation model
I Megiddo, A Colson, D Chisholm, T Dua, A Nandi, R Laxminarayan
Epilepsia 57 (3), 464-474, 2016
2802016
COVID-19 vaccination in lower-middle income countries: national stakeholder views on challenges, barriers, and potential solutions
ET Tagoe, N Sheikh, A Morton, J Nonvignon, AR Sarker, L Williams, ...
Frontiers in Public Health 9, 709127, 2021
1102021
Reduced burden of childhood diarrheal diseases through increased access to water and sanitation in India: A modeling analysis
A Nandi, I Megiddo, A Ashok, A Verma, R Laxminarayan
Social Science & Medicine 180, 181-192, 2017
892017
Analysis of the Universal Immunization Programme and introduction of a rotavirus vaccine in India with IndiaSim
I Megiddo, AR Colson, A Nandi, S Chatterjee, S Prinja, A Khera, ...
Vaccine 32, A151-A161, 2014
502014
Indoor air pollution, Disease control priorities in developing countries
N Bruce, E Rehfuess, S Mehta, G Hutton, K Smith, D Jamison, J Breman, ...
Oxford University Press, New York. doi 10, 978-0, 2006
50*2006
Evaluating intervention strategies in controlling coronavirus disease 2019 (COVID-19) spread in care homes: An agent-based model
S Howick, D McLafferty, GH Anderson, SJ Pravinkumar, R Van Der Meer, ...
Infection Control & Hospital Epidemiology 42 (9), 1060-1070, 2021
442021
Antimicrobial resistance: is health technology assessment part of the solution or part of the problem?
AR Colson, A Morton, C Årdal, K Chalkidou, SC Davies, LP Garrison, M Jit, ...
Value in Health 24 (12), 1828-1834, 2021
292021
Universal health coverage for mental, neurological, and substance use disorders: an extended cost-effectiveness analysis
D Chisholm, KA Johansson, N Raykar, I Megiddo, A Nigam, KB Strand, ...
Mental, neurological, and substance use disorders, 237, 2016
282016
Simulation models for transmission of health care–associated infection: A systematic review
I Megiddo, S Howick
American journal of infection control 48 (7), 810-821, 2020
252020
Economic and epidemiological impact of dengue illness over 16 years from a public health system perspective in Brazil to inform future health policies including the adoption of …
IP Godói, LVD Da Silva, AR Sarker, I Megiddo, A Morton, B Godman, ...
Expert review of vaccines 17 (12), 1123-1133, 2018
242018
Economic and epidemiological impact of dengue illness over 16 years from a public health system perspective in Brazil to inform future health policies including the adoption of …
IP Godói, LVD Da Silva, AR Sarker, I Megiddo, A Morton, B Godman, ...
Expert review of vaccines 17 (12), 1123-1133, 2018
242018
Quantifying uncertainty about future antimicrobial resistance: Comparing structured expert judgment and statistical forecasting methods
AR Colson, I Megiddo, G Alvarez-Uria, S Gandra, T Bedford, A Morton, ...
PloS one 14 (7), e0219190, 2019
232019
Health and economic benefits of scaling up a home-based neonatal care package in rural India: a modelling analysis
A Nandi, AR Colson, A Verma, I Megiddo, A Ashok, R Laxminarayan
Health policy and planning 31 (5), 634-644, 2016
232016
Cost-effectiveness of treatment and secondary prevention of acute myocardial infarction in India: a modeling study
I Megiddo, S Chatterjee, A Nandi, R Laxminarayan
Global heart 9 (4), 391-398. e3, 2014
232014
Impact of visitation and cohorting policies to shield residents from covid-19 spread in care homes: an agent-based model
S Howick, D McLafferty, GH Anderson, SJ Pravinkumar, R Van Der Meer, ...
American Journal of Infection Control 49 (9), 1105-1112, 2021
192021
Self-enforcing regional vaccination agreements
P Klepac, I Megiddo, BT Grenfell, R Laxminarayan
Journal of The Royal Society Interface 13 (114), 20150907, 2016
172016
Potential impact of introducing the pneumococcal conjugate vaccine into national immunisation programmes: an economic-epidemiological analysis using data from India
I Megiddo, E Klein, R Laxminarayan
BMJ global health 3 (3), e000636, 2018
162018
Investing in antibiotics to alleviate future catastrophic outcomes: What is the value of having an effective antibiotic to mitigate pandemic influenza?
I Megiddo, D Drabik, T Bedford, A Morton, J Wesseler, R Laxminarayan
Health Economics 28 (4), 556-571, 2019
152019
Evaluations of heat action plans for reducing the health impacts of extreme heat: methodological developments (2012–2021) and remaining challenges
IJ Dwyer, SJE Barry, I Megiddo, CJ White
International journal of biometeorology 66 (9), 1915-1927, 2022
142022
Hybrid simulation modelling of networks of heterogeneous care homes and the inter-facility spread of Covid-19 by sharing staff
LKN Nguyen, I Megiddo, S Howick
PLoS Computational Biology 18 (1), e1009780, 2022
142022
The system can't perform the operation now. Try again later.
Articles 1–20